Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Aluminum in neurological disease - a 36 year multicenter study.

Lukiw WJ, Kruck TPA, Percy ME, Pogue AI, Alexandrov PN, Walsh WJ, Sharfman NM, Jaber VR, Zhao Y, Li W, Bergeron C, Culicchia F, Fang Z, McLachlan DRC.

J Alzheimers Dis Parkinsonism. 2019;8(6). pii: 457. doi: 10.4172/2161-0460.1000457. Epub 2018 Nov 29.

2.

Aluminum in Neurological and Neurodegenerative Disease.

McLachlan DRC, Bergeron C, Alexandrov PN, Walsh WJ, Pogue AI, Percy ME, Kruck TPA, Fang Z, Sharfman NM, Jaber V, Zhao Y, Li W, Lukiw WJ.

Mol Neurobiol. 2019 Feb;56(2):1531-1538. doi: 10.1007/s12035-018-1441-x. Epub 2019 Jan 31.

PMID:
30706368
3.

Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.

Islam MT.

Neurol Res. 2017 Jan;39(1):73-82. Epub 2016 Nov 3. Review.

PMID:
27809706
4.

Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.

Oeckl P, Steinacker P, von Arnim CA, Straub S, Nagl M, Feneberg E, Weishaupt JH, Ludolph AC, Otto M.

J Proteome Res. 2014 Nov 7;13(11):4518-25. doi: 10.1021/pr5006058. Epub 2014 Aug 13.

PMID:
25091646
5.
6.

Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies.

Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, Balanzá-Martínez V, Climent J, Valencia A, McGrath J, Crespo-Facorro B, Sanchez-Moreno J, Vieta E, Tabarés-Seisdedos R.

Psychother Psychosom. 2014;83(2):89-105. doi: 10.1159/000356498. Epub 2014 Jan 22.

PMID:
24458030
7.
8.

[The other dementias: the neuropathology of the non-Alzheimer's disease dementias].

Hamilton RL.

Rev Neurol. 2003 Jul 16-31;37(2):130-9. Review. Spanish.

9.

Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Armstrong RA, Cairns NJ.

J Neural Transm (Vienna). 2015 Oct;122(10):1355-67. doi: 10.1007/s00702-015-1402-8. Epub 2015 May 1. Erratum in: J Neural Transm (Vienna). 2015 Oct;122(10):1369-70.

PMID:
25929331
10.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
11.

Prion protein immunohistochemical staining in the brains of monkeys with transmissible spongiform encephalopathy.

Baker HF, Ridley RM, Wells GA, Ironside JW.

Neuropathol Appl Neurobiol. 1998 Dec;24(6):476-86.

PMID:
9888158
12.

The nucleus basalis of Meynert in neurological disease: a quantitative morphological study.

Rogers JD, Brogan D, Mirra SS.

Ann Neurol. 1985 Feb;17(2):163-70.

PMID:
3883886
13.

[Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].

Dervaux A, Vicart S, Lopes F, Le Borgne MH.

Encephale. 2001 Mar-Apr;27(2):194-7. French.

PMID:
11407273
14.

Cholinesterase inhibitors for rarer dementias associated with neurological conditions.

Li Y, Hai S, Zhou Y, Dong BR.

Cochrane Database Syst Rev. 2015 Mar 3;(3):CD009444. doi: 10.1002/14651858.CD009444.pub3. Review.

PMID:
25734590
15.

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.

Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D, Hurtig HI, Chen-Plotkin A, Wolk DA, McCluskey LF, Elman LB, Trojanowski JQ, Umansky SR.

Alzheimers Res Ther. 2017 Nov 9;9(1):89. doi: 10.1186/s13195-017-0316-0.

17.

[Creutzfeldt-Jakob disease--a human prion disease].

Buchwald E, Vorstrup S.

Nord Med. 1996 Jun;111(6):180-3. Review. Danish.

PMID:
8700643
18.

[Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].

Zaborowski A.

Psychiatr Pol. 2004 Mar-Apr;38(2):283-96. Review. Polish.

PMID:
15307293
19.

Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).

Pogue AI, Lukiw WJ.

Cell Mol Neurobiol. 2018 Jul;38(5):1021-1031. doi: 10.1007/s10571-017-0572-3. Epub 2018 Jan 4.

PMID:
29302837
20.

Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.

Smith TW, Lippa CF.

J Neuropathol Exp Neurol. 1995 May;54(3):297-303.

PMID:
7745428

Supplemental Content

Support Center